Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP
Articolo
Data di Pubblicazione:
1995
Abstract:
The experimental observation that plasma from TTP patients sometimes exhibits a protein which can cause platelet agglutination, and that such agglutination can be inhibited in vitro by the use of IgG led some authors to treat plasma exchange-resistant TTP patients with high-dose IgG (HDIgG).
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Adult; Aged; Aspirin; Combined Modality Therapy; Female; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Plasma Exchange; Purpura, Thrombocytopenic, Idiopathic; Remission Induction; Retrospective Studies; Salvage Therapy; Severity of Illness Index; Treatment Outcome; Immunization, Passive
Elenco autori:
Centurioni, R; Bobbio-Pallavicini, E; Porta, C; Rodeghiero, F; Gugliotta, L; Billio, A; Tacconi, F; Ascari, E
Link alla scheda completa:
Pubblicato in: